Protara Therapeutics's market cap is currently $135.56M. The company's EPS TTM is $-2.821; its P/E ratio is ―; Protara Therapeutics is scheduled to report earnings on March 5, 2025, and the estimated EPS forecast is $-0.56. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ -341.00K	$ -247.00K	$ -1.17M	$ -196.00K	$ -16.00K
Operating Income	$ -43.61M	$ -67.06M	$ -47.49M	$ -34.44M	$ -15.25M
EBITDA	$ -43.27M	$ -64.57M	$ -46.09M	$ -33.78M	$ -7.81M
Net Income	$ -40.42M	$ -64.81M	$ -47.13M	$ -33.51M	$ -14.73M
Balance Sheet
Cash & Short-Term Investments	$ 65.58M	$ 84.37M	$ 91.23M	$ 168.60M	$ 6.18M
Total Assets	$ 78.95M	$ 113.29M	$ 172.60M	$ 203.16M	$ 6.97M
Total Debt	$ 5.47M	$ 6.38M	$ 7.24M	$ 1.09M	$ 0.00
Net Debt	$ -34.12M	$ -17.74M	$ -28.48M	$ -167.51M	$ -6.18M
Total Liabilities	$ 10.63M	$ 11.21M	$ 10.68M	$ 3.91M	$ 583.00K
Stockholders' Equity	$ 68.32M	$ 102.08M	$ 161.91M	$ 199.24M	$ 6.39M
Cash Flow
Free Cash Flow	$ -37.60M	$ -26.58M	$ -35.10M	$ -24.29M	$ -15.66M
Operating Cash Flow	$ -37.56M	$ -26.46M	$ -34.50M	$ -23.41M	$ -15.65M
Investing Cash Flow	$ 53.11M	$ 14.95M	$ -98.19M	$ 2.83M	$ 2.48M
Financing Cash Flow	$ -91.00K	$ -90.00K	$ -228.00K	$ 189.40M	$ 500.00K

Currency in USD

Protara Therapeutics Earnings and Revenue History

Income Statement >

Protara Therapeutics Debt to Assets

Balance Sheet >

Protara Therapeutics Cash Flow

Cash Flow >

Protara Therapeutics Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing